Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EASYMADE-TI

K-Number: K252251 · 2026-04-09

Decision Date2026-04-09
Product CodeGXN
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

EASYMADE-TI is the device name listed in this FDA 510(k) record. The listed applicant is CG Bio Co., Ltd.. It received FDA 510(k) clearance on 2026-04-09 under 510(k) number K252251. The device is classified under product code GXN. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EASYMADE-TI?

EASYMADE-TI is a medical device that received FDA 510(k) clearance on 2026-04-09. The listed applicant is CG Bio Co., Ltd.. The 510(k) number is K252251.

When did EASYMADE-TI receive FDA 510(k) clearance?

EASYMADE-TI received FDA 510(k) clearance on 2026-04-09, under 510(k) number K252251.

Who is the listed applicant for EASYMADE-TI?

The FDA 510(k) record lists CG Bio Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for EASYMADE-TI?

The FDA product code for EASYMADE-TI is GXN.

Other records listing CG Bio Co., Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: GXN)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.